American Century Companies Trims Stake in Zimmer Biomet

Asset manager reduces holdings in medical device firm by 9.3% in Q3

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

American Century Companies Inc. cut its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 9.3% in the third quarter, according to a recent SEC filing. The fund now owns 5,176,696 shares of the medical equipment provider's stock, worth approximately $509.9 million.

Why it matters

Zimmer Biomet is a major player in the orthopedic and musculoskeletal healthcare industry, so changes in institutional ownership of the stock can signal shifts in investor sentiment around the company and the broader sector.

The details

American Century reduced its position in Zimmer Biomet by selling 532,674 shares during the quarter. The asset manager now owns about 2.61% of the company's outstanding shares. Zimmer Biomet's stock has seen volatility in recent quarters as the company navigates challenges in the medical device market, including supply chain disruptions and inflationary pressures.

  • American Century filed its Q3 2026 13F report in late February 2026.

The players

American Century Companies Inc.

A global asset management firm that oversees over $200 billion in client assets.

Zimmer Biomet Holdings, Inc.

A leading manufacturer of orthopedic implants and surgical products for the musculoskeletal healthcare industry.

Got photos? Submit your photos here. ›

The takeaway

American Century's reduced stake in Zimmer Biomet reflects broader uncertainty in the medical device sector, as companies navigate supply chain challenges and inflationary pressures. However, Zimmer Biomet remains a major player in the orthopedics market, and changes in institutional ownership of the stock can provide insights into investor sentiment around the company and the industry.